DE602005009255D1 - Amid-prodrug von gemcitabin, zusammensetzungen und verwendung damit - Google Patents

Amid-prodrug von gemcitabin, zusammensetzungen und verwendung damit

Info

Publication number
DE602005009255D1
DE602005009255D1 DE602005009255T DE602005009255T DE602005009255D1 DE 602005009255 D1 DE602005009255 D1 DE 602005009255D1 DE 602005009255 T DE602005009255 T DE 602005009255T DE 602005009255 T DE602005009255 T DE 602005009255T DE 602005009255 D1 DE602005009255 D1 DE 602005009255D1
Authority
DE
Germany
Prior art keywords
gemcitabin
amid
prodrug
compositions
amid prodrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005009255T
Other languages
English (en)
Inventor
David Michael Bender
David Michael Remick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE602005009255D1 publication Critical patent/DE602005009255D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602005009255T 2004-12-17 2005-11-30 Amid-prodrug von gemcitabin, zusammensetzungen und verwendung damit Active DE602005009255D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63742204P 2004-12-17 2004-12-17
PCT/US2005/043125 WO2006065525A1 (en) 2004-12-17 2005-11-30 Amide prodrug of gemcitabine, compositions and use thereof

Publications (1)

Publication Number Publication Date
DE602005009255D1 true DE602005009255D1 (de) 2008-10-02

Family

ID=36168678

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005009255T Active DE602005009255D1 (de) 2004-12-17 2005-11-30 Amid-prodrug von gemcitabin, zusammensetzungen und verwendung damit

Country Status (32)

Country Link
US (1) US7691827B2 (de)
EP (1) EP1831237B1 (de)
JP (1) JP5022911B2 (de)
KR (1) KR100874052B1 (de)
CN (1) CN101080417B (de)
AR (1) AR055009A1 (de)
AT (1) ATE405573T1 (de)
AU (1) AU2005316922B2 (de)
BR (1) BRPI0519117A2 (de)
CA (1) CA2589850C (de)
CY (1) CY1108447T1 (de)
DE (1) DE602005009255D1 (de)
DK (1) DK1831237T3 (de)
EA (1) EA011868B1 (de)
ES (1) ES2310860T3 (de)
HK (1) HK1109903A1 (de)
HR (1) HRP20080529T3 (de)
IL (1) IL183666A (de)
MA (1) MA29154B1 (de)
MX (1) MX2007007228A (de)
MY (1) MY143677A (de)
NO (1) NO20073368L (de)
NZ (1) NZ554732A (de)
PE (1) PE20060771A1 (de)
PL (1) PL1831237T3 (de)
PT (1) PT1831237E (de)
RS (1) RS50629B (de)
SI (1) SI1831237T1 (de)
TW (1) TWI326687B (de)
UA (1) UA86119C2 (de)
WO (1) WO2006065525A1 (de)
ZA (1) ZA200705019B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101448504B (zh) * 2006-06-21 2012-04-11 伊莱利利公司 吉西他滨酰胺前体药物的结晶形式、其组合物以及用途
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
CN104955458A (zh) 2012-11-07 2015-09-30 Z·索 取代的吉西他滨芳基酰胺类似物和使用所述类似物的治疗方法
JP6420247B2 (ja) 2012-11-13 2018-11-07 ボーイエン セラピューティクス，インコーポレイティド ゲムシタビンプロドラッグ及びその使用
US10059733B2 (en) 2014-03-03 2018-08-28 Nucorion Pharmaceuticals, Inc. Gemcitabine analogs
WO2016078160A1 (zh) * 2014-11-17 2016-05-26 常州方圆制药有限公司 胞苷衍生物及其应用
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
CA3091027A1 (en) 2018-02-02 2019-08-08 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate
AU2019258590B2 (en) * 2018-04-26 2022-09-08 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
CN108864250A (zh) * 2018-05-29 2018-11-23 北京大学 一种FAPα酶敏感的吉西他滨前体药物及其制备方法和应用
CA3108362A1 (en) * 2018-08-03 2020-02-06 Cellix Bio Private Limited Compositions and methods for the treatment of cancer
EP4143199A1 (de) 2020-04-21 2023-03-08 Ligand Pharmaceuticals, Inc. Nukleotid-prodrug-verbindungen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
AU720451B2 (en) * 1997-01-24 2000-06-01 Conpharma As Gemcitabine derivatives
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
EP1567169A4 (de) * 2002-11-04 2009-10-21 Xenoport Inc Gemcitabin-prodrugs, phramazeutische zusammensetzungen und verwendungen davon
US7846436B2 (en) * 2003-11-28 2010-12-07 Chemgenes Corporation Oligonucleotides and related compounds

Also Published As

Publication number Publication date
JP5022911B2 (ja) 2012-09-12
EA011868B1 (ru) 2009-06-30
MY143677A (en) 2011-06-30
TW200634023A (en) 2006-10-01
US20090156547A1 (en) 2009-06-18
ATE405573T1 (de) 2008-09-15
SI1831237T1 (sl) 2009-02-28
PE20060771A1 (es) 2006-09-23
KR100874052B1 (ko) 2008-12-12
EP1831237B1 (de) 2008-08-20
KR20070086308A (ko) 2007-08-27
EP1831237A1 (de) 2007-09-12
BRPI0519117A2 (pt) 2008-12-23
CY1108447T1 (el) 2014-04-09
RS50629B (sr) 2010-06-30
MX2007007228A (es) 2007-08-14
AU2005316922A1 (en) 2006-06-22
US7691827B2 (en) 2010-04-06
CA2589850A1 (en) 2006-06-22
ZA200705019B (en) 2008-10-29
IL183666A (en) 2011-09-27
JP2008524218A (ja) 2008-07-10
EA200701300A1 (ru) 2007-10-26
AR055009A1 (es) 2007-08-01
AU2005316922B2 (en) 2011-08-25
NZ554732A (en) 2010-09-30
UA86119C2 (ru) 2009-03-25
NO20073368L (no) 2007-07-16
CA2589850C (en) 2012-05-01
MA29154B1 (fr) 2008-01-02
IL183666A0 (en) 2007-09-20
PL1831237T3 (pl) 2009-01-30
HK1109903A1 (en) 2008-06-27
CN101080417B (zh) 2011-01-19
PT1831237E (pt) 2008-09-22
CN101080417A (zh) 2007-11-28
ES2310860T3 (es) 2009-01-16
DK1831237T3 (da) 2008-10-27
WO2006065525A1 (en) 2006-06-22
TWI326687B (en) 2010-07-01
HRP20080529T3 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
DE602005009255D1 (de) Amid-prodrug von gemcitabin, zusammensetzungen und verwendung damit
ATE486597T1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
ATE419849T1 (de) Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
ATE428710T1 (de) Substituierte phenylaminothiazole und ihre verwendung
ATE430145T1 (de) 3-ä(2-ä 4-(hexyloxycarbonylamino-imino-methyl)- phenylaminoü-methylü-1-methyl-1h-benzimidazol-5 carbonyl)-pyridin-2-yl-aminoü -propionsäure- ethylester -methansulfonat und dessen verwendung als arzneimittel
ATE440093T1 (de) 1-alkinyl-2-aryloxyalkylamide und ihre verwendung als fungizide
DE602006010243D1 (de) 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen
DE602005003186D1 (de) Fluorkopolymer und dessen Verwendung
CY1110026T1 (el) Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων
ATE428417T1 (de) Derivate von piperidinylalkylcarbamaten, herstellungsverfahren davon und verwendung derselben als faah-enzym-inhibitoren
ATE479437T1 (de) Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
ATE511507T1 (de) Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
DE602005009988D1 (de) Härtbare Zusammensetzung und deren Verwendung
DE602006018166D1 (de) Polyrotaxanhaltige lösung und verwendung davon
ATE420081T1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
ATE451923T1 (de) N-(arylalkyl)-1h-pyrrolopyridin-2-carboxamid- derivate, ihre herstellung und verwendung
ATE468338T1 (de) Pyrrolochinolinderivate und ihre verwendung als proteinkinasehemmer
DE602004028700D1 (de) Kosmetische Zusammensetzungen und deren Verwendung
DE602006006861D1 (de) Herstellung von polytrimethylenetherglykol und copolymeren davon
DE602006006710D1 (de) Herstellung von polytrimethylenetherglykol und copolymeren davon
DE602006008025D1 (de) Amidverbindungen und deren verwendung
DE602005007866D1 (de) 1-phenyl- und 1-pyridylpyrazolderivate und deren verwendung als pestizide
ATE441647T1 (de) N-amidderivate von 8-azabicycloä3.2.1üoct-3-yl als ccr1-antagonisten
BRPI0614481A2 (pt) composto, composição farmecêutica, uso do composto, e, método de tratamento de distúrbios mediados por mglur5

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN